Dr. Peter Beitsch on Pertuzumab in Luminal Subtype Breast Cancer OncLive 2:31 8 years ago 431 Далее Скачать
Dr. Peter Beitsch on Pertuzumab in the Luminal Subtype of HER2-Positive Breast Cancer Targeted Oncology 1:28 8 years ago 217 Далее Скачать
Dr. Peter Beitsch on the Benefits of Grouping Patients With Breast Cancer by Subtype for Trials Targeted Oncology 1:03 8 years ago 125 Далее Скачать
Dr Beitsch says all breast cancer patients deserve genetic testing Pat Whitworth 3:33 6 years ago 39 Далее Скачать
Dr. Pegram on Pertuzumab Combination for HER2-Positive Breast Cancer OncLive 1:53 7 years ago 457 Далее Скачать
Experts Comment, Agendia Breast Cancer Assays - Peter Beitsch, MD Agendia Inc 0:27 11 years ago 558 Далее Скачать
Dr. Pat Whitworth on Importance of the Luminal Subtype in Breast Cance Targeted Oncology 1:18 8 years ago 522 Далее Скачать
Dr. Pegram on Pertuzumab Plus Trastuzumab and Chemotherapy in Breast Cancer OncLive 1:05 7 years ago 227 Далее Скачать
Dr. Mark Pegram on Combining Trastuzumab and Pertuzumab OncLive 1:06 11 years ago 1 052 Далее Скачать
Pertuzumab, trastuzumab and cyclophosphamide in older patients with HER2+ breast cancer VJOncology 4:29 2 years ago 481 Далее Скачать
Dr. Pegram on Pertuzumab and Trastuzumab in Breast Cancer Targeted Oncology 2:12 11 years ago 1 131 Далее Скачать
Dr. Kolberg on Cost-Effectiveness of Pertuzumab in HER2-Positive Breast Cancer OncLive 1:51 8 years ago 267 Далее Скачать
PRECIOUS: pertuzumab retreatment in patients with HER+ breast cancer VJOncology 1:40 1 year ago 177 Далее Скачать
Dr. Yee on Neoadjuvant Pertuzumab in HER2-Positive Breast Cancer OncLive 0:47 9 years ago 302 Далее Скачать
Dr. Pegram Discusses Adjuvant Pertuzumab in HER2+ Breast Cancer OncLive 1:13 6 years ago 147 Далее Скачать
Trastuzumab (Herceptin) and Pertuzumab (Perjeta) for Breast Cancer: What You Need to Know Yerbba – Breast Cancer 8:31 3 months ago 3 793 Далее Скачать
Targeted Therapies for Breast Cancer: A Breakthrough in Treatment Cancer Treatment Updates 0:22 7 months ago 430 Далее Скачать
Endocrine therapy plus trastuzumab and pertuzumab shows excellent survival outcomes in HR and HE... ecancer 5:58 4 weeks ago 20 Далее Скачать